Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined versus single bowel cleansing regimen for colonoscopy preparation
IRCT20260420069109N1Phase 3Recruiting
- Sponsor
- Alborz University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sodium picosulfate, magnesium oxide, citric acid, macrogol, bisacodyl and 1 more (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoint: Quality of bowel cleansing. Started Sep 2026; status: recruiting.
02
Drugs
sodium picosulfatemagnesium oxidecitric acidmacrogolbisacodyl
Beyond the preview
Go deeper on IRCT20260420069109N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260420069109N1.